PURECYCLE TECHNOLOGIES INC (PCT)

US74623V1035 - Common Stock

10.75  +0.68 (+6.75%)

After market: 10.85 +0.1 (+0.93%)

Fundamental Rating

2

PCT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 84 industry peers in the Chemicals industry. PCT may be in some trouble as it scores bad on both profitability and health. PCT is valued expensive and it does not seem to be growing.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

PCT had negative earnings in the past year.
In the past year PCT has reported a negative cash flow from operations.
PCT had negative earnings in each of the past 5 years.
In the past 5 years PCT always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -9.79%, PCT is not doing good in the industry: 83.95% of the companies in the same industry are doing better.
The Return On Equity of PCT (-24.20%) is worse than 85.19% of its industry peers.
Industry RankSector Rank
ROA -9.79%
ROE -24.2%
ROIC N/A
ROA(3y)-10.43%
ROA(5y)-6.53%
ROE(3y)-20.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

PCT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

3

2. Health

2.1 Basic Checks

PCT has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, PCT has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.11, we must say that PCT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of PCT (1.11) is worse than 77.78% of its industry peers.
A Debt/Equity ratio of 1.21 is on the high side and indicates that PCT has dependencies on debt financing.
With a Debt to Equity ratio value of 1.21, PCT is not doing good in the industry: 75.31% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF N/A
Altman-Z 1.11
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 2.92 indicates that PCT has no problem at all paying its short term obligations.
PCT's Current ratio of 2.92 is fine compared to the rest of the industry. PCT outperforms 79.01% of its industry peers.
A Quick Ratio of 2.92 indicates that PCT has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.92, PCT belongs to the top of the industry, outperforming 90.12% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.92
Quick Ratio 2.92

More info and screens

3

3. Growth

3.1 Past

PCT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -157.92%.
EPS 1Y (TTM)-157.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1900%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, PCT will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.60% on average per year.
Based on estimates for the next years, PCT will show a very strong growth in Revenue. The Revenue will grow by 490.25% on average per year.
EPS Next Y-156.04%
EPS Next 2Y-6.74%
EPS Next 3Y10.53%
EPS Next 5Y15.6%
Revenue Next Year2863.62%
Revenue Next 2Y2189.73%
Revenue Next 3Y905.64%
Revenue Next 5Y490.25%

3.3 Evolution

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

PCT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PCT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.74%
EPS Next 3Y10.53%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PCT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PURECYCLE TECHNOLOGIES INC

NASDAQ:PCT (1/3/2025, 8:00:01 PM)

After market: 10.85 +0.1 (+0.93%)

10.75

+0.68 (+6.75%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-15 2024-11-15/amc
Earnings (Next)N/A N/A
Inst Owners81.37%
Inst Owner Change0%
Ins Owners3.5%
Ins Owner Change-0.12%
Market Cap1.87B
Analysts78
Price Target13.86 (28.93%)
Short Float %23.58%
Short Ratio13.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)77.2%
Min EPS beat(2)35.6%
Max EPS beat(2)118.8%
EPS beat(4)2
Avg EPS beat(4)-11.18%
Min EPS beat(4)-173.23%
Max EPS beat(4)118.8%
EPS beat(8)4
Avg EPS beat(8)-9.63%
EPS beat(12)5
Avg EPS beat(12)-60.09%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-100%
Min Revenue beat(2)-100%
Max Revenue beat(2)-100%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.54%
PT rev (3m)47.64%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-23.99%
EPS NY rev (3m)-38.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-1.17%
Revenue NY rev (3m)-76.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.44
P/tB 4.44
EV/EBITDA N/A
EPS(TTM)-1.37
EYN/A
EPS(NY)-0.71
Fwd EYN/A
FCF(TTM)-1.43
FCFYN/A
OCF(TTM)-0.55
OCFYN/A
SpS0
BVpS2.42
TBVpS2.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.79%
ROE -24.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-10.43%
ROA(5y)-6.53%
ROE(3y)-20.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 965.79%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.92
Quick Ratio 2.92
Altman-Z 1.11
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)4982.36%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-157.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1900%
EPS Next Y-156.04%
EPS Next 2Y-6.74%
EPS Next 3Y10.53%
EPS Next 5Y15.6%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year2863.62%
Revenue Next 2Y2189.73%
Revenue Next 3Y905.64%
Revenue Next 5Y490.25%
EBIT growth 1Y-40.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year72.88%
EBIT Next 3Y36.95%
EBIT Next 5Y57.01%
FCF growth 1Y29.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-44.94%
OCF growth 3YN/A
OCF growth 5YN/A